The global blood cancers testing sector is exhibiting significant growth, propelled by a rising prevalence of leukemia and other related diseases. Analysts estimate the present market scope to be substantial, with projections indicating a steady compound annual growth rate (CAGR) over the projected period. Key trends shaping the industry include… Read More